AstraZeneca Pharma India Limited
ICICI Prudential Mutual Fund increased its stake in AstraZeneca Pharma India Limited from 1.12% to 2.18%. The fund house acquired 2,63,843 shares, taking its total holding to 5,43,837 shares.
A pharmaceutical manufacturer and distributor operating across India, AstraZeneca Pharma India engages in the production, distribution, and marketing of medicines spanning multiple therapeutic areas. The company serves hospitals, clinics, and retail pharmacies through its extensive distribution network and manufacturing facilities. Its core operations focus on delivering quality pharmaceutical products and treatments to healthcare providers and patients nationwide.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.